Psidium cattleianum fruit extract prevents systemic alterations in an animal model of type 2 diabetes mellitus: comparison with metformin effects

Biomarkers. 2023 Mar;28(2):238-248. doi: 10.1080/1354750X.2022.2163695. Epub 2023 Jan 4.

Abstract

Objective: In this study, we aimed to determine the role of Psidium cattleianum extract (PCE) and compare its effects with those of metformin (Met) in an animal model with type 2 diabetes mellitus (T2DM).Methods: T2DM was induced in rats using a high-fat diet (HFD), followed by a single dose of streptozotocin (STZ). Met and PCE were administered intragastrically once a day throughout the experiment, and their effects on biochemical, inflammatory, oxidative, and histological parameters were evaluated.Results: Met and PCE prevented the increase in serum levels of glucose, total cholesterol (TC), triacylglycerol (TG), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) induced by T2DM, and restored redox homeostasis in the liver and brain. Met increased the serum levels of anti-inflammatory cytokine and interleukin-10 (IL-10). Furthermore, both treatments restored the liver and pancreas from marked cellular disorganisation, vacuolisation, and necrosis, with PCE being more effective than Met in recovering histological changes.Conclusion: PCE is a promising agent for the prevention of T2DM complications.

Keywords: Diabetes; animal model; metformin; oxidative stress; phenolic compounds.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Blood Glucose
  • Diabetes Mellitus, Experimental* / drug therapy
  • Diabetes Mellitus, Experimental* / pathology
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / pathology
  • Fruit
  • Hypoglycemic Agents / pharmacology
  • Metformin* / pharmacology
  • Metformin* / therapeutic use
  • Models, Animal
  • Psidium*
  • Rats

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Metformin